Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DIETARY SUPPLEMENT HEALTH CLAIMS STATUS QUO UNDER NLEA

This article was originally published in The Tan Sheet

Executive Summary

DIETARY SUPPLEMENT HEALTH CLAIMS STATUS QUO UNDER NLEA would be maintained for more than two years or until a special commission devises a process for reviewing claims under the version of S 784 that cleared the Senate Aug. 13. According to a summary of the bill from sponsor Sen. Orrin Hatch (R-Utah), "dietary supplements will be subject to the preapproval process and standard of the Nutrition Labeling & Education Act for the two-year period that a new, independent Commission on Dietary Supplement Labeling determines the most appropriate process" of evaluating health claims.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel